Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-06
1999-12-14
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 514 17, 514 18, 514903, 530327, 530328, 530329, 530330, A61K 3800
Patent
active
060018097
ABSTRACT:
This invention provides peptides which block cellular adhesion mediated by VLA-4. The peptides can be used to treat a number of inflammatory diseases, in particular, inflammatory brain disorders.
REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4542124 (1985-09-01), Huffman et al.
patent: 4837028 (1989-06-01), Allen
patent: 5066716 (1991-11-01), Robey et al.
patent: 5473051 (1995-12-01), Altieri et al.
patent: 5510332 (1996-04-01), Kogan et al.
Elices, et al., Cell, 60:577-584 (1990).
Springer, Nature, 346:425-434 (1990).
Osborn, Cell, 62:3-6 (1990).
Vedder, et al., Surgery, 106:509-516 (1989).
Pretolani, et al., J. Exp. Med., 180:795-805 (1994).
Abraham, et al., J. Clin. Invest., 93:776-787 (1994).
Mulligan, et al., J. Immunology, 150(6):2407-2417 (1993).
Cybulsky, et al., Science, 251:788-790 (1991).
Li, et al., Arterioslcer. Thromb., 13(2):197-204 (1993).
Sasseville, et al., Am. J. Path., 144(1):27-40 (1994).
Yang, et al., Proc. Nat. Acad. Science (USA), 90:10494-10498 (1993).
Burkly, et al., Diabetes, 43:529-534 (1994).
Baron, et al., J. Clin. Invest., 93:1700-1708 (1994).
Hamann, et al., J. Immunology, 152:3282-3293 (1994).
Yednock, et al., Nature, 356:63-66 (1992).
Baron, et al., J. Exp. Med., 177:57-68 (1993).
van Dinther-Janssen, et al., J. Immunology, 147(12):4207-4210 (1991).
van Dinther-Janssen, et al., Annals. Rheumatic Dis., 52:672-676 (1993).
Elices, et al., J. Clin. Invest., 93:405-416 (1994).
Postigo, et al., J. Clin. Invest., 89:1445-1452 (1992).
Paul, et al., Transpl. Proceed., 25(1):813-814 (1993).
Okarhara, et al., Can. Res., 54:3233-3236 (1994).
Paavonen, et al., Int. J. Can., 58:298-302 (1994).
Schadendorf, et al., J. Path., 170:429-434 (1993).
Bao, et al., Diff., 52:239-246 (1993).
Lauri, et al., British J. Cancer, 68:862-867 (1993).
Kawaguchi, et al., Japanese J. Cancer Res., 83:1304-1316 (1992).
Matteucci, et al., J. Am. Chem. Soc. 103:3185-3191 (1981).
Robey, et al., Anal. Biochem., 177:373-377 (1989).
Verhoef, et al., Eur. J. Drug Metab. Pharmacokin., 11(4):291-302 (1986).
Langer, Science, 249:1527-1535 (1990).
Szoka et al., Ann. Rev. Biophys. Bioeng., 9:467-508 (1980).
Wayner and Kovach, J. Cell Biol., 116(2):489-497 (1992).
Vonderheide, et al., J. Cell Biol., 125(1):215-222 (1994).
van de Weil-van Kemenade, et al., J. Cell Biol., 117(2):461-470 (1992).
Arroyo, et al., J. Cell Biol., 117(3):659-670 (1992).
Vilhardt et al., Journal of Pharmacology, 232, pp. 223-226, 1993.
Smith et al., Cancer Research, vol. 45, pp. 6119-6123, 1985.
Kopple, Kenneth, Peptides and Amino Acids, pp. 32-51, 1966.
Caplus AN: 1986:32815, Smith et al., Cancer Research., 45 (12, pt. 1), 6119-23, 1985.
Pleiss Michael A.
Thorsett Eugene D.
Yednock Theodore A.
Delacroix-Muirheid C.
Duvall Jean M.
Elan Pharmaceuticals Inc.
Stratford Carol A.
Tsang Cecilia J.
LandOfFree
Inhibitors of leukocyte adhesion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of leukocyte adhesion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of leukocyte adhesion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863474